Andrew Arno - 03 Apr 2023 Form 4 Insider Report for Oncocyte Corp (OCX)

Role
Director
Signature
/s/ Andrew Arno
Issuer symbol
OCX
Transactions as of
03 Apr 2023
Net transactions value
+$150,001
Form type
4
Filing time
05 Apr 2023, 21:29:28 UTC
Previous filing
31 Jan 2023
Next filing
27 Jun 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OCX Common Stock, no par value Award $50,000 +141,084 +27% $0.3544 673,133 03 Apr 2023 Direct
transaction OCX Common Stock, no par value Award $50,000 +141,084 +941% $0.3544 156,084 03 Apr 2023 See footnote F1
transaction OCX Common Stock, no par value Award $50,000 +141,084 +941% $0.3544 156,084 03 Apr 2023 See footnote F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares of the Issuer's common stock, no par value ("Common Stock"), are held by JBA Investments LLC ("JBA"). The Reporting Person is the Manager of JBA and in such capacity has the right to vote and dispose of securities held by JBA.
F2 These shares of Common Stock are held by MJA Investments LLC ("MJA"). The Reporting Person is the Manager of MJA and in such capacity has the right to vote and dispose of securities held by MJA.